Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study
A Naghipour, E Amini-Salehi… - Systematic …, 2023 - Springer
Background Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is
closely associated with metabolic conditions such as obesity and diabetes mellitus, which …
closely associated with metabolic conditions such as obesity and diabetes mellitus, which …
The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis
E Amini-Salehi, S Hassanipour, MH Keivanlou… - Nutrition …, 2024 - academic.oup.com
Context Nonalcoholic fatty liver disease (NAFLD) is considered the leading cause of chronic
liver disease worldwide. To date, no confirmed medication is available for the treatment of …
liver disease worldwide. To date, no confirmed medication is available for the treatment of …
Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses
A Mahapatro, F Bawna, V Kumar, AA Daryagasht… - Clinical nutrition …, 2023 - Elsevier
Background and aim The impact of chronic low-grade inflammation in the development of
non-alcoholic fatty liver disease (NAFLD) has been studied widely. Previous studies showed …
non-alcoholic fatty liver disease (NAFLD) has been studied widely. Previous studies showed …
The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
A Vakilpour, E Amini-Salehi, A Soltani Moghadam… - Nutrition & …, 2024 - nature.com
Background Type 2 diabetes mellitus (T2DM) is a significant risk factor for non-alcoholic fatty
liver disease (NAFLD). Increased fasting blood sugar (FBS), fasting insulin (FI), and insulin …
liver disease (NAFLD). Increased fasting blood sugar (FBS), fasting insulin (FI), and insulin …
[HTML][HTML] Association between smoking and colorectal cancer in Eastern Mediterranean Regional Office (EMRO): A systematic review and meta-analysis
MH Keivanlou, E Amini-Salehi… - Saudi Journal of …, 2023 - journals.lww.com
Background: Smoking poses a significant risk for colorectal cancer (CRC), considered the
third leading reason for cancer-related deaths worldwide. However, there has been limited …
third leading reason for cancer-related deaths worldwide. However, there has been limited …
Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary …
M Javid, A Mirdamadi, M Javid… - Annals of Medicine …, 2023 - journals.lww.com
Method: Two researchers searched through PubMed, Scopus, and Web of Science in
November 2022 to find articles that examined GGT levels in CIN patients following PCI or …
November 2022 to find articles that examined GGT levels in CIN patients following PCI or …
Global prevalence of nonalcoholic fatty liver disease: An updated review meta-analysis comprising a population of 78 million from 38 countries
E Amini-Salehi, N Letafatkar, N Norouzi… - Archives of Medical …, 2024 - Elsevier
Background Nonalcoholic fatty liver disease (NAFLD) is a global health challenge, with a
rising rate in line with other metabolic diseases. We aimed to assess the global prevalence …
rising rate in line with other metabolic diseases. We aimed to assess the global prevalence …
[HTML][HTML] The ability of ChatGPT in paraphrasing texts and reducing plagiarism: a descriptive analysis
S Hassanipour, S Nayak, A Bozorgi… - JMIR Medical …, 2024 - mededu.jmir.org
Background: The introduction of ChatGPT by OpenAI has garnered significant attention.
Among its capabilities, paraphrasing stands out. Objective: This study aims to investigate the …
Among its capabilities, paraphrasing stands out. Objective: This study aims to investigate the …
Potential impact of ezetimibe on patients with NAFLD/NASH: a meta-analysis of randomized controlled trials
BL Jiao, B Wang, BY Liu, J Zhao… - Frontiers in …, 2024 - frontiersin.org
Background Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of
chronic liver disease. Studies have found that ezetimibe may be utilized as a supplemental …
chronic liver disease. Studies have found that ezetimibe may be utilized as a supplemental …
Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023
A Mahapatro, A Bozorgi, SUJ Obulareddy… - Annals of Medicine …, 2024 - journals.lww.com
Background: In recent years, glucagon-like peptide-1 (GLP-1) agonists have garnered
increasing attention for their potential cardiovascular benefits beyond glycemic control in …
increasing attention for their potential cardiovascular benefits beyond glycemic control in …